LEXINGTON, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene …
~ Following Type C Meeting with the U.S. Food & Drug Administration (FDA), Strongbridge Plans to Submit its New Drug Application (NDA) for RECORLEV™ (levoketoconazole) in the Third Quarter of 2020; Submission to Include Data From the Phase 3 SONICS and …
FORT LAUDERDALE, Fla., May 01, 2019 (GLOBE NEWSWIRE) -- Templeton Global Income Fund [NYSE: GIM] today announced a monthly distribution from net investment income of $0.0354 per share, payable on May 31, 2019, to shareholders of record on May 15, 2019 (Ex- …
FORT LAUDERDALE, Fla., May 01, 2019 (GLOBE NEWSWIRE) -- Templeton Emerging Markets Income Fund [NYSE: TEI] today announced a monthly distribution from net investment income of $0.0669 per share, payable on May 31, 2019, to shareholders of record on May 15, …
JOHNS CREEK, Ga., May 01, 2019 (GLOBE NEWSWIRE) -- Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries today announced that its EbixCash …
Tarrytown, NY, May 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nightfood, Inc. (OTCQB: NGTF), the innovative ice cream company solving America’s $50 billion-dollar nighttime snacking problem, announced today that the company has scheduled a fourth ice …
ATCHISON, Kan., May 01, 2019 (GLOBE NEWSWIRE) -- MGP Ingredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and specialty wheat proteins and starches, today announced that its board of directors has declared a quarterly dividend …
OXNARD, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has extended the close of the previously announced acquisition of Chemistry Holdings Inc …
SMi Reports: Registration is now open for the Air Missile Defence Technology conference, taking place in Prague, Czech Republic this October. LONDON, UNITED KINGDOM, May 1, 2019 /EINPresswire.com/ -- With militaries constantly facing varied threats, …
FOSTER CITY, Calif. and HANGZHOU, China, May 01, 2019 (GLOBE NEWSWIRE) -- Apollomics, Inc. (the “Company”), an innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies, today announced that Fabio M. …
LINCOLNSHIRE, Ill., May 01, 2019 (GLOBE NEWSWIRE) -- CDW Corporation (NASDAQ:CDW), today announced that its Board of Directors has declared a quarterly cash dividend of $0.295 per common share to be paid on June 11, 2019, to all stockholders of record as …
SALT LAKE CITY, May 01, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced that it will be presenting at two upcoming healthcare conferences. R. Bryan Riggsbee, chief …
- SCS injection platform continues to be well-received by the medical community - - Suprachoroidal administration may offer targeted delivery of gene therapies without risks of vitrectomy and subretinal surgery - ALPHARETTA, Ga., May 01, 2019 (GLOBE …
NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its …
RICHARDSON, Texas, May 01, 2019 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (NASDAQ: FOSL) announced today that its earnings for the first quarter ended March 30, 2019 will be released following the market close on Wednesday, May 8, 2019. In conjunction with …
SAN CARLOS, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it …
WAYNE, Pa., May 01, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory and dermatological diseases, today announced it will report financial results for the first …
SAN FRANCISCO, May 01, 2019 (GLOBE NEWSWIRE) -- Preempt, the leading provider of conditional access for real-time threat prevention, today announced a partnership with Okta, Inc. (NASDAQ:OKTA), the leading provider of cloud identity for the enterprise, to …
(Dollars in millions, except per-share amounts) Three Months Ended March 31, 2019 Three Months Ended March 31, 2018 % Chg. Net Sales $ 3,957.9 $ 3,606.4 9.7 Average Daily Sales1 62.8 56.4 11.5 Gross Profit 672.1 603.9 11.3 Operating …
SOUTH SAN FRANCISCO, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Wednesday, May 8th, 2019 at 4:30 p.m. Eastern Time to discuss corporate updates and financial …
